Meet our oncology team in Madrid.
ESMO 2026 is the European Society for Medical Oncology’s flagship congress, drawing more than 30,000 clinicians, researchers, and industry partners to Madrid from 23–27 October. It remains the central meeting point for the oncology community, a place where late-breaking data, trial strategy, and the next wave of cancer care come into focus.
Representing OCT Clinical at this year’s congress will be Kseniia Korchagina, Director of Business Development.
Our team has managed oncology studies across a broad range of solid tumors and hematologic indications, with a particular focus on trials run across Central and Eastern European sites. If you are planning a study and want a candid read on feasibility, patient access, or startup timelines in Europe, we are offering complimentary feasibility assessments during the congress window.
If you would like to arrange a meeting in Madrid, reach out directly at kkorchagina@octclinicalgroup.com. We are happy to talk through trial design, site selection, study management, or registration strategy—whatever is most useful for your program right now.
